Cardio3 BioSciences
Latest round
- Series B
Last raised
- Jan 2009
Total raised
- $9.5M
Investors
- 2
About Cardio3 BioSciences
Cardio3 BioSciences, headquartered in Mont-Saint-Guibert (Belgium), is a biopharmaceutical company, founded in 2007, and focused on the discovery, development and commercialization of regenerative and protective therapies for cardiovascular diseases.
Who invested in Cardio3 BioSciences
2 investors across 1 round
See all investors in Cardio3 BioSciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 19, 2009
Amount
$9.5M
Investors
Questions about Cardio3 BioSciences
Who invested in Cardio3 BioSciences?
Cardio3 BioSciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cardio3 BioSciences raised?
Cardio3 BioSciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cardio3 BioSciences last raise money?
Cardio3 BioSciences's most recent round on record is a Series B, in Jan 2009.
What does Cardio3 BioSciences do?
Cardio3 BioSciences, headquartered in Mont-Saint-Guibert (Belgium), is a biopharmaceutical company, founded in 2007, and focused on the discovery, development and commercialization of regenerative and protective therapies for cardiovascular diseases.
Where is Cardio3 BioSciences headquartered?
Cardio3 BioSciences is headquartered in Belgium.
Which VCs invest in companies like Cardio3 BioSciences?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Cardio3 BioSciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Cardio3 BioSciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.